1. Bromodomains as therapeutic targets in cancer
    I. Barbieri et al, 2013, Briefings in Functional Genomics CrossRef
  2. Haploinsufficiency ofSGO1results in deregulated centrosome dynamics, enhanced chromosomal instability and colon tumorigenesis
    Hiroshi Y. Yamada et al, 2012, Cell Cycle CrossRef
  3. Targeting the Bromome: are we there yet?
    Susanne Müller, 2016, Future Medicinal Chemistry CrossRef
  4. Antagonizing pathways leading to differential dynamics in colon carcinogenesis in Shugoshin1 (Sgo1)-haploinsufficient chromosome instability model
    Chinthalapally V. Rao et al, 2016, Mol. Carcinog. CrossRef
  5. null
    Panagis Filippakopoulos et al, 2016 CrossRef
  6. Discovery of Chemical Inhibitors of Human Bromodomains
    Guangtao Zhang et al, 2015, Chem. Rev. CrossRef
  7. MiR-185 attenuates androgen receptor function in prostate cancer indirectly by targeting bromodomain containing 8 isoform 2, an androgen receptor co-activator
    Chen-Yi Jiang et al, 2016, Molecular and Cellular Endocrinology CrossRef
  8. Fusion of the genes BRD8 and PHF1 in endometrial stromal sarcoma.
    Francesca Micci et al, 2017, Genes Chromosomes Cancer CrossRef
  9. null
    Liliya Tyutyunyk-Massey et al, 2018 CrossRef
  10. SRSF3 maintains transcriptome integrity in oocytes by regulation of alternative splicing and transposable elements
    Dang Vinh Do et al, 2018, Cell Discov CrossRef
  11. Cellular Depletion of BRD8 Causes p53-Dependent Apoptosis and Induces a DNA Damage Response in Non-Stressed Cells
    Anahita Lashgari et al, 2018, Sci Rep CrossRef
  12. Novel immune–risk score of gastric cancer: A molecular prediction model combining the value of immune–risk status and chemosensitivity
    Shijie Duan et al, 2019, Cancer Med CrossRef
  13. null
    Susanne Müller et al, 2014 CrossRef
  14. FunDMDeep-m6A: identification and prioritization of functional differential m6A methylation genes
    Song-Yao Zhang et al, 2019 CrossRef
  15. Bromodomain biology and drug discovery
    Nilesh Zaware et al, 2019, Nat Struct Mol Biol CrossRef
  16. BRD8, which is negatively regulated by miR-876-3p, promotes the proliferation and apoptosis resistance of hepatocellular carcinoma cells via KAT5.
    Zhaoxiang Yu et al, 2020, Arch Biochem Biophys CrossRef
  17. The Bromodomain Containing 8 (BRD8) Transcriptional Network in Human Lung Epithelial Cells
    James A. Browne et al, 2021, Molecular and Cellular Endocrinology CrossRef
  18. Machine Learning for Building Immune Genetic Model in Hepatocellular Carcinoma Patients
    Jun Liu et al, 2021, Journal of Oncology CrossRef
  19. Ossifying low grade endometrial stromal sarcoma with PHF1-BRD8 fusion
    Paul Chih-Hsueh Chen et al, 2021, Cancer Genetics CrossRef
  20. Chemoproteomics Enabled Discovery of Selective Probes for NuA4 Factor BRD8
    David Remillard et al, 2021, ACS Chem. Biol. CrossRef
  21. The Regulatory Role of RNA Metabolism Regulator TDP-43 in Human Cancer
    Xueyou Ma et al, 2021, Front. Oncol. CrossRef
  22. Bromodomain (BrD) Family Members as Regulators of Cancer Stemness—A Comprehensive Review
    Patrycja Czerwinska et al, 2023, IJMS CrossRef
  23. Bromodomain protein BRD8 regulates cell cycle progression in colorectal cancer cells through a TIP60-independent regulation of the pre-RC complex
    Kiyoshi Yamaguchi et al, 2023, iScience CrossRef
  24. null
    Nathan R. Rose et al, 2010 CrossRef
  25. Molecular mechanisms of TWIST1‐regulated transcription in EMT and cancer metastasis
    Xiaobin Yu et al, 2023, EMBO Reports CrossRef
  26. Targeting bromodomian-containing protein 8 (BRD8): An advanced tool to interrogate BRD8
    Tingting Wu et al, 2024, European Journal of Medicinal Chemistry CrossRef